Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Equillium (0A4D) vs. Competitors

2 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
GB:0A4DEquillium$1.35$90.04M-5.1136.23%Strong BuyUnlock the GB:0A4D analyst price target with TipRanks PremiumGB:0A4DUnlock the GB:0A4D top-analyst price target with TipRanks Premium
NRXPNRX Pharmaceuticals$2.28$106.50M-3.08-13.64%Strong BuyUnlock the NRXP analyst price target with TipRanks PremiumGB:0A4D vs NRXPUnlock the NRXP top-analyst price target with TipRanks Premium
STROSutro Biopharma$9.59$170.12M-0.5518.28%Moderate BuyUnlock the STRO analyst price target with TipRanks PremiumGB:0A4D vs STROUnlock the STRO top-analyst price target with TipRanks Premium
HYFTMindWalk Holdings$1.00$49.00M-3.79-44.13%Strong BuyUnlock the HYFT analyst price target with TipRanks PremiumGB:0A4D vs HYFTUnlock the HYFT top-analyst price target with TipRanks Premium
PRLDPrelude Therapeutics$3.52$301.66M-4.49139.46%Moderate BuyUnlock the PRLD analyst price target with TipRanks PremiumGB:0A4D vs PRLDUnlock the PRLD top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
GB:0A4DEquillium1.350.4652.37%
NRXPNRX Pharmaceuticals2.28-0.31-11.97%
STROSutro Biopharma9.590.303.23%
HYFTMindWalk Holdings1.00-0.65-39.39%
PRLDPrelude Therapeutics3.522.01133.11%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts